This protein, which can be measured with a blood test, has emerged as an indicator of Alzheimer’s disease pathology. Analysis of this low-p-Tau217 subgroup was defined in the SHINE study design in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback